Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- Influenza Diagnostics Market, By Product Type
5.1 Introduction
5.2 Traditional Diagnostic Tests
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Molecular Diagnostic Tests
5.3.1 Market Overview
5.3.2 Market Size and Forecast
- Influenza Diagnostics Market, By End User
6.1 Introduction
6.2 Hospitals
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Home Care Settings
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Other End Users
6.4.1 Market Overview
6.4.2 Market Size and Forecast
- Influenza Diagnostics Market, By Geography
7.1 Introduction
7.2 Europe
7.2.1 Europe Market, By Product Type
7.2.2 Europe Market, By End User
7.3 North America
7.3.1 North America Market, By Product Type
7.3.2 North America Market, By End User
7.4 Asia Pacific
7.4.1 Asia Pacific Market, By Product Type
7.4.2 Asia Pacific Market, By End User
7.5 Rest of The World
7.5.1 Rest of The World Market, By Product Type
7.5.2 Rest of The World Market, By End User
- Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
- Company Profiles
9.1 Hoffmann-La Roche AG
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Quidel Corporation
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Thermo Fisher Scientific Inc.
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Abbott Laboratories, Inc.
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Hologic Inc
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Becton Dickinson
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Roche Diagnostics
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Alere Scarborough, Inc
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Princeton Bio MedTech crop
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Sekisui Diagnostics
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments